About ENYO Pharma

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
60 avenue Rockefeller, 69008 LYON, France, Bioserra 1, Bâtiment B, Lyon, Rhône-Alpes 69008, FR
Description
Information
ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Roughly 30-50% of NASH patients have CKD through common bidirectional pathways leading to severe renal impairment. Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.

ENYO Pharma Alternatives

Frequently Asked Questions about ENYO Pharma

What is ENYO Pharma email format?

The widely used ENYO Pharma email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is ENYO Pharma customer service number?

To contact ENYO Pharma customer service number in your country click here to find.


Who is the CEO of ENYO Pharma?

Carole Dubreuil is the CEO of ENYO Pharma. To contact Carole Dubreuil email at [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more